Table 4.

Mean Symptom Scale Scores by cGVHD Disease Site

Symptom Scales	No cGVHD Reference (n = 19)	Eyes (n = 47)	Mouth (n = 31)	Skin (n = 28)	Lungs (n = 27)	Joints (n = 24)	GI Tract (n = 18)
IDAS
Depression	35.1	37.2	38.6	42.4 *	40.7	42.3	43.4 *
	(8.7)	(9.4)	(8.9)	(11.4)	(12.0)	(13.4)	(10.4)
Panic	10.4	12.4	14.3 *	12.9	13.4 *	13.3 *	15.3 *
	(3.2)	(4.4)	(4.6)	(4.6)	(4.6)	(4.9)	(5.7)
Intrusive Thoughts	4.6	4.9	5.1	5.5	5.1	5.5	5.6
	(1.0)	(1.3)	(1.5)	(2.0)	(1.5)	(2.2)	(1.8)
FSI
Intensity	3.0	3.6	3.9	4.1*	4.2*	4.1	4.4 *
	(2.0)	(1.9)	(1.8)	(1.9)	(2.0)	(2.2)	(1.8)
Interference	1.5	1.8	2.3	2.9 *	2.7	2.8	2.9 *
	(1.9)	(2.2)	(2.3)	(2.3)	(2.5)	(2.4)	(2.1)
BPI
Intensity	1.5	2.0	2.6	2.9 *	2.6	2.8	3.2 *
	(1.9)	(2.1)	(2.3)	(2.3)	(2.3)	(2.7)	(2.3)
Interference	1.3	1.9	2.4	2.8 *	2.4	2.9*	2.8
	(1.9)	(2.3)	(2.4)	(2.4)	(2.5)	(2.9)	(2.5)
ISI
Total	8.0	7.3	8.3	9.4	8.6	9.3	9.1
	(6.2)	(4.9)	(5.0)	(4.4)	(5.7)	(4.7)	(4.4)
PROMIS
Cognition	20.5	21.1	20.7	19.3	21.4	20.5	18.9
	(5.7)	(4.2)	(4.4)	(4.5)	(4.6)	(4.2)	(4.1)
Sexual Function	2.7	1.7	1.2 *	1.6	1.3 *	1.6	0.6 *
	(1.9)	(1.8)	(1.6)	(1.9)	(1.9)	(2.0)	(1.1)
LSS
Total	N/A	50.2	53.0	54.6	52.4	56.0	56.5
		(11.3)	(10.5)	(11.2)	(12.8)	(11.3)	(12.0)

Note. Standard deviations are shown in parentheses. Disease sites are not mutually exclusive. Some participants are in more than one disease site category.

^*=p < .05 for comparison between reference and subgroup. Bolded values are statistically significant after FDR procedure.